Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.501 USD | -9.71% | -18.67% | -95.45% |
05-24 | Allarity Therapeutics, Inc. Concludes Its Phase 2 Clinical Trial | CI |
05-06 | Allarity Therapeutics Says Stockholders' Equity 'Significantly' Exceeds Nasdaq's $2.5 Million Minimum Rule | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-95.45% | 155K | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ALLR Stock
- News Allarity Therapeutics, Inc.
- Transcript : Allarity Therapeutics A/S - Shareholder/Analyst Call